Dr. John Dugan, MD
NPI: 1154677755
Total Payments
$3,600
2024 Payments
$1,040
Companies
27
Transactions
194
Medicare Patients
3,824
Medicare Billing
$447,841
Payment Breakdown by Category
Food & Beverage$3,586 (99.6%)
Education$13.76 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,586 | 193 | 99.6% |
| Education | $13.76 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,096 | 59 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $518.85 | 39 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $379.33 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $219.82 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $207.94 | 10 | $0 (2024) |
| Braintree Laboratories, Inc. | $161.55 | 8 | $0 (2021) |
| Celgene Corporation | $129.26 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $120.12 | 6 | $0 (2022) |
| PFIZER INC. | $111.83 | 5 | $0 (2024) |
| Torax Medical, Inc. | $103.35 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,040 | 58 | ABBVIE INC. ($424.56) |
| 2023 | $800.36 | 44 | AbbVie Inc. ($322.15) |
| 2022 | $415.36 | 22 | ABBVIE INC. ($160.77) |
| 2021 | $260.55 | 14 | AbbVie Inc. ($75.99) |
| 2020 | $282.47 | 15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($64.53) |
| 2019 | $349.39 | 20 | Takeda Pharmaceuticals U.S.A., Inc. ($124.98) |
| 2018 | $172.47 | 10 | AbbVie, Inc. ($31.52) |
| 2017 | $279.94 | 11 | Torax Medical, Inc. ($103.35) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/31/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Immunology | ||||||
| 10/01/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Neuroscience | ||||||
| 08/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 925 | 1,005 | $160,948 | $106,722 |
| 2022 | 9 | 1,016 | 1,122 | $181,761 | $123,350 |
| 2021 | 9 | 992 | 1,156 | $172,021 | $117,544 |
| 2020 | 8 | 891 | 1,036 | $154,821 | $100,225 |
Total Patients
3,824
Total Services
4,319
Medicare Billing
$447,841
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 219 | 222 | $46,981 | $22,555 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 221 | $28,707 | $21,247 | 74.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 91 | 93 | $23,890 | $19,123 | 80.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $16,714 | $12,242 | 73.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 127 | $11,645 | $8,410 | 72.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 84 | 87 | $12,192 | $7,313 | 60.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $9,513 | $6,854 | 72.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 19 | 19 | $4,692 | $3,272 | 69.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 13 | 13 | $2,434 | $2,351 | 96.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 27 | $2,187 | $1,755 | 80.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $1,993 | $1,599 | 80.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 270 | 275 | $57,143 | $33,252 | 58.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 271 | $36,157 | $26,986 | 74.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 131 | 131 | $22,753 | $16,469 | 72.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 76 | 78 | $20,526 | $15,810 | 77.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 103 | 117 | $16,819 | $9,752 | 58.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 122 | $11,553 | $8,209 | 71.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 92 | 92 | $10,724 | $7,234 | 67.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 21 | 21 | $4,008 | $3,988 | 99.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $2,078 | $1,649 | 79.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 209 | 331 | $44,518 | $32,455 | 72.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 221 | 222 | $46,294 | $27,062 | 58.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 64 | 64 | $16,865 | $13,290 | 78.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 103 | 103 | $17,931 | $13,041 | 72.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 142 | 175 | $16,595 | $12,222 | 73.6% |
About Dr. John Dugan, MD
Dr. John Dugan, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1154677755.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Dugan, MD has received a total of $3,600 in payments from pharmaceutical and medical device companies, with $1,040 received in 2024. These payments were reported across 194 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,586).
As a Medicare-enrolled provider, Dugan has provided services to 3,824 Medicare beneficiaries, totaling 4,319 services with total Medicare billing of $447,841. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gastroenterology
- Location Houston, TX
- Active Since 08/01/2012
- Last Updated 04/20/2016
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1154677755
Products in Payments
- XIFAXAN (Drug) $407.66
- VIBERZI (Drug) $276.88
- CREON (Drug) $210.20
- DIFICID (Drug) $206.92
- SKYRIZI (Biological) $200.97
- STELARA (Biological) $192.23
- LINZESS (Drug) $191.94
- ZEPOSIA (Drug) $129.26
- INJECTAFER (Drug) $120.12
- XELJANZ (Drug) $111.83
- RINVOQ (Biological) $109.22
- SUPREP BOWEL PREP (Drug) $105.15
- LINX (Device) $103.35
- DUPIXENT (Biological) $101.31
- Entyvio (Biological) $100.99
- ENTYVIO (Biological) $99.26
- EOHILIA (Drug) $85.51
- TRULANCE (Drug) $83.58
- HUMIRA (Biological) $67.85
- Humira (Biological) $67.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Houston
Sandeep Sahay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $366,850
Student in an Organized Health Care Education/Training Program $366,850
Diego Marines Copado, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $287,975
Student in an Organized Health Care Education/Training Program $287,975
Dr. Eddie Patton, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $235,342
Student in an Organized Health Care Education/Training Program $235,342
Naveen Pemmaraju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $198,556
Student in an Organized Health Care Education/Training Program $198,556
Laila Tabatabai, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $194,524
Student in an Organized Health Care Education/Training Program $194,524
Syed Naqvi, M.d./M.b.a, M.D./M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $144,401
Student in an Organized Health Care Education/Training Program $144,401